ArticleScientific reports2025
Biochemical mechanisms of flonicamid resistance and its transgenerational effects in Bemisia tabaci mitotype Asia-II-1.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bemisia tabaci is amongst noxious pest of the cotton, vegetables and ornamentals. Insecticides, for instance neonicotinoids, carbamates, organophosphates and pyrethroids are employed to control B. tabaci. Owing to the excessive use of chemicals, high level of resistance has been developed in B. tabaci. Flonicamid, a systemic insecticide inhibits insect's feeding and is potent against B. tabaci. The potential mechanisms underlying resistance to flonicamid in B. tabaci Asia-II-1 were investigated for 16 generations and biochemical assays were performed for the possible involvement of enzymes in the resistance development. In addition, the transgenerational effects were also assessed. Flonicamid resistant strain was developed with 161.5 folds increase in resistance at 16th generation (LC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.